Skip to main content
. 2018 Nov 7;38(6):BSR20180752. doi: 10.1042/BSR20180752

Table 1. Characteristics of patients from SEER Database by gender.

Number of patients (%)
Characteristic Total Male Female
n=6586 n=4049 n=2537 P value
Media follow up (mo) 17(5–20) 17(5–19) 19(5–22)
(IQR)
Years of diagnosis 0.533
  2000–2004 3469(52.7) 2145(53.0) 1324(52.2)
  2005–2008 3117(47.3) 1904(47.0) 1213(47.8)
Age 0.296
  <40 581(8.8) 358(8.8) 223(8.8)
  41–60 3635(55.2) 2263 (55.9) 1372(54.1)
  >60 2370(36.0) 1428(35.3) 942(37.1)
Race P<0.001
  Caucasian 5425(82.4) 3361(83.0) 878(34.6)
  African American 914(13.9) 384(9.5) 312(12.3)
  Others* 2282(34.6) 1712(42.3) 209(8.2)
Primary site 0.870
  Cerebrum 235(3.6) 144(3.6) 91(3.6)
  Frontal lobe 1663(25.3) 1028(25.4) 635(25.0)
  Temporal lobe 1556(23.6) 957(23.6) 599(23.6)
  Parietal lobe 1097(16.7) 661(16.3) 436(17.2)
  Occipital lobe 274(4.2) 158(3.9) 116(4.6)
  Ventricle, NOS 27(0.4) 15(0.4) 12(0.5)
  Cerebellum, NOS 36(0.5) 22(0.5) 14(0.6)
  Brain stem 28(0.5) 19(0.5) 9(0.4)
  Overlapping lesion of brain 1158(17.6) 719(17.8) 439(17.3)
  Brain, NOS 512(7.8) 326(8.1) 186(7.3)
Pathological grading 0.144
  High/Moderate 25(0.4) 20 (0.5) 5 (0.2)
  Poor/UD 2655(40.3) 1640(40.5) 1015(40.0)
  Unknown 3906(59.3) 2389(59.0) 1517(59.8)
Stage 0.127
  Localized 5067(76.9) 3152 (77.8) 1915(75.5)
  Regional 1172(17.8) 697(17.2) 475 (18.7)
  Distant 70(1.1) 38(0.9) 32(1.3)
  Unstaged 277(4.2) 162(4.0) 115(4.5)
Tumor size 0.015
  <3 cm 797 (12.1) 463 (11.4) 334 (13.2)
  3–5 cm 2498(37.9) 1511(37.3) 987 (38.9)
  >5 cm 1666(25.3) 1071(26.5) 595(23.5)
  Not stated 1625(24.7) 1004(24.8) 621(24.5)

Abbreviation: NOS, not otherwise specified.

*

including other (American Indian/AK Native, Asian/Pacific Islander) and unknowns.